6
1 The Cancer Risk Associated with Ethylene Oxide in the Processing of Cord Blood Byron Butterworth, Ph.D. Butterworth Consulting John Chapman, Ph.D. ThermoGenesis Corp. March 30, 2007

The Cancer Risk Associated with Ethylene Oxide in the Processing of Cord Blood

Embed Size (px)

DESCRIPTION

The Cancer Risk Associated with Ethylene Oxide in the Processing of Cord Blood. Byron Butterworth, Ph.D. Butterworth Consulting John Chapman, Ph.D. ThermoGenesis Corp. March 30, 2007. Stem Cells in Cord Blood. - PowerPoint PPT Presentation

Citation preview

Page 1: The Cancer Risk Associated with Ethylene Oxide in the Processing of Cord Blood

1

The Cancer Risk Associated with Ethylene Oxide in the Processing

of Cord Blood

Byron Butterworth, Ph.D.Butterworth ConsultingJohn Chapman, Ph.D.ThermoGenesis Corp.

March 30, 2007

Page 2: The Cancer Risk Associated with Ethylene Oxide in the Processing of Cord Blood

2

Stem Cells in Cord Blood

• Are used to repopulate the bone marrow of chemotherapy patients – a process involving extensive cell division

• Are long lived, continuously dividing cells that create all hematopoietic progenitor cells for the lifetime of the patient

• Absolutely NO mutagenic changes are acceptable that could yield precancerous or cancerous cells

Page 3: The Cancer Risk Associated with Ethylene Oxide in the Processing of Cord Blood

3

Ethylene Oxide (EtO)

• Proposed Sterilant for cord blood processing disposables

• FDA is proposing to allow 5 mg/disposable• EtO is a potent direct-acting, DNA reactive

mutagen and clastogen• Produces lymphoma and/or leukemia in

mice, rats and human beings• Thus, these DNA cancer target sites are

subject to mutagenic attack by EtO

Page 4: The Cancer Risk Associated with Ethylene Oxide in the Processing of Cord Blood

4

Susceptibility Concerns

• Stem cells would be directly exposed to the DNA reactive mutagen EtO during processing– No anatomic barriers or detoxification mechanisms

• Proliferating cells are highly susceptible to mutation induction by DNA reactive agents

• L5178Y cells grown on plastic culture flasks sterilized with EtO result in mutation frequency increases of 6- to 14-fold

Page 5: The Cancer Risk Associated with Ethylene Oxide in the Processing of Cord Blood

5

There is No “Safe” Dose of Ethylene Oxide

• Current FDA guidance would allow concentrations in the range of 30 to 100 g/ml of EtO in cord blood preparations

• No data are available that demonstrate the safety of these concentrations or any concentration of EtO for stem cell exposure

• FDA and EPA cancer risk models recognize no “safe” or “threshold” dose for direct acting mutagens

Page 6: The Cancer Risk Associated with Ethylene Oxide in the Processing of Cord Blood

6

Only Gamma Irradiation or Steam should be allowed for Sterilization

• The cancer risk of ethylene oxide can be eliminated simply by the use of gamma irradiation or steam for the sterilization of all products for cord blood processing and storage

• Units of stored cord blood exposed to ethylene oxide should not be used without the transplant physician being made aware of the exposure

• New labeling for ethylene oxide exposed cord blood units should be considered